TP53 Missense-Specific Transcriptional Plasticity Drives Resistance against Cell Cycle Inhibitors in Pancreatic Cancer

Integrating multicenter patient data and multi-omics, scientists reported that the misp53^R273H/C mutant is associated with cell cycle progression and a basal-like state compared to the misp53R248W/Q mutant.